Intracanalicular optic nerve injury is the most common form of traumatic optic neuropathy and is accompanied by a high incidence of canal fracture. For the past 20 years treatment with high-dose ...
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study.
A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...